Subscribe To
Virios Therapeutics Announces First Quarter 2023 Financial Results
ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”), today announced financial results for the first quarter ended March 31, 2023. Key Highlights The Company proposed a Phase 3 program for its […] The post Virios Therapeutics Announces First Quarter 2023 Financial Results appeared first on For...
Read More
Posted: May 11 2023, 11:05
Author Name: forextv
Views: 110881